Mogrify has collected $17m in a second series A tranche led by Parkwalk Advisors to bring the round’s total to $33m.

Mogrify, a UK-based cell conversion technology developer with links to Bristol, Monash and Duke universities, secured $17m in a series A extension yesterday to bring the round’s total to $33m. Parkwalk Advisors, the fund management subsidiary of commercialisation firm IP Group, led the second close, which also included Astellas Venture Management, the corporate venturing arm…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.